TOLSA additives active against viruses

TOLSA, a global leader in the extraction, treatment and commercialization of mineral solutions, has announced that its biocidal additives, ADINS® Protection range, demonstrate viricidal activity.

The COVID-19 crisis has posed health challenges to society and precautionary activities such as hygiene and disinfection have gained unprecedented importance, influencing markets and enhancing new advantages related to ADINS® Protection Series additives.

TOLSA reports that ADINS® Protection S10 has shown to be highly active against all enveloped viruses including Coronavirus type, along with Norovirus, Rotavirus, and Adenovirus, according to the EN 14476 standard.

These tests conducted by an independent international external laboratory have confirmed that ADINS® Protection S10 reduces the viral load by up to 99.99% in both short and long periods. ADINS® Protection not only shows viricidal activity, but also bactericide, fungicide, and algicide activity. 

TOLSA’s biocidal silver-based products present, due to its stability, a high antimicrobial activity at lower dosages. In addition, these products allow an optimal dispersion into the matrix in which they are incorporated.

ADINS® Protection is a powder solution that can be used in different formulations for applications such as construction (i.e., joint mortars), plastics and rubbers, textiles, and paints and coatings.

                                                                                                                                                  TOLSA has one of the most extensive and differentiated range of special clays worldwide, offering a broad range of additives and industrial products that provide high added value and improve the performance and efficiency of materials. The company also develops mineral applications that directly or indirectly improve the lives of people throughout the world. The company develops its own raw materials and controls the chain of production and logistics. TOLSA’s significant investment in R&D and lab operations supports the development of diverse applications in a broad range of markets.